Search Results - "Lozano Blázquez, Ana"

Evaluate to train by Negro-Vega, Eva, Lozano-Blázquez, Ana

Get more information

Exacerbation of a thrombotic thrombocytopenic purpura episode linked to different P2Y12 inhibitors in the same patient. Case report by Macía-Rivas, Lola, Maray, Iván, Fernández-Laguna, Clara L., Álvarez-Asteinza, Cristina, Lozano-Blázquez, Ana

Get full text

A case of pyoderma gangrenosum associated to bevacizumab, angiogenesis role in its etiology by Maray-Mateos, Iván, Álvarez-Asteinza, Cristina, Carbajales-Álvarez, Mónica, Lozano-Blázquez, Ana

Get full text

Differences in cancer drug assessment between Spain and the United Kingdom by Lozano-Blázquez, Ana, Dickson, Rumona, Fraga-Fuentes, María-Dolores, Martínez-Martínez, Fernando, Calleja-Hernández, Miguel-Ángel

“…Abstract Objectives There is no Spanish Government agency resembling the National Institute for Health and Care Excellence (NICE) in the United Kingdom (UK)…”
Get full text

Pharmacotherapeutic management of advanced therapy medicinal products by Poveda-Andrés, José Luis, Ruiz-Caldes, María José, Carreras-Soler, María José, Clopés-Estela, Ana, Flores-Moreno, Sandra, García-Pellicer, Javier, Giráldez-Quiroga, Míriam, López-Briz, Eduardo, Lozano-Blázquez, Ana, Megías-Vericat, Juan Eduardo, Tordera-Baviera, María, Valero-García, Silvia

“…Advanced therapy medicinal products have emerged In recent years as new pharmacotherapeutic strategies. In this context, hospital pharmacy services have had to…”
Get full text

A case of pyoderma gangrenosum associated to bevacizumab, angiogenesis role in its etiology by Maray-Mateos, Iván, Álvarez-Asteinza, Cristina, Carbajales-Álvarez, Mónica, Lozano-Blázquez, Ana

Get more information

Drug assessment by a Pharmacy and Therapeutics committee: from drug selection criteria to use in clinical practice by Lozano-Blázquez, Ana, Calvo-Pita, Cecilia, Carbajales-Álvarez, Mónica, Suárez-Gil, Patricio, Martínez-Martínez, Fernando, Calleja-Hernández, Miguel Ángel

“…In Spain, hospital medicines are assessed and selected by local Pharmacy and Therapeutics committees (PTCs). Of all the drugs assessed, cancer drugs are…”
Get full text

[Artículo traducido] Exacerbación de un episodio de púrpura trombótica trombocitopénica relacionado con diferentes inhibidores de P2Y12 en un mismo paciente. A propósito de un caso by Macía-Rivas, Lola, Maray, Ivan, Fernández-Laguna, Clara L., Álvarez-Asteinza, Cristina, Lozano-Blázquez, Ana

Get full text

Spanish Society of Hospital Pharmacy position paper on biosimilar medicines by Martínez-López de Castro, Noemí, Matilla-Fernández, María Belén, Fraga-Fuentes, María Dolores, Mangues-Bafalluy, Irene, Asensi-Díez, Rocío, Cajaraville-Ordoñana, Gerardo

“…Biological medicines nowadays have a great impact, as they offer treatment for  diverse diseases and suppose a high cost for health system. Biosimilar…”
Get more information

Real-world Data Study of the Efficacy and Toxicity of Nivolumab vs . Cetuximab and Predictors of Response to Nivolumab in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck in a European Population by Macia-Rivas, Lola, Fernandez-Laguna, Clara Luz, Alvarez-Asteinza, Cristina, Maray, Ivan, Carbajales-Alvarez, Monica, Lozano-Blazquez, Ana

“…This study aimed to assess the effectiveness and safety of nivolumab versus cetuximab in patients with Recurrent/Metastatic Squamous Cell Carcinoma of the Head…”
Get more information

Exacerbation of a thrombotic thrombocytopenic purpura episode linked to different P2Y12 inhibitors in the same patient. Case report by Macía-Rivas, Lola, Maray, Ivan, Fernández-Laguna, Clara L, Álvarez-Asteinza, Cristina, Lozano-Blázquez, Ana

Get more information

Dose reduction and toxicity of lenalidomide-dexamethasone in multiple myeloma: A machine-learning prediction model by Maray, Iván, Álvarez-Asteinza, Cristina, Fernández-Laguna, Clara Luz, Macía-Rivas, Lola, Carbajales-Álvarez, Mónica, Lozano-Blazquez, Ana

“…Purpose Lenalidomide remains an effective drug for multiple myeloma, but it is often associated with adverse events and requires dose adjustments. The…”
Get full text

Pharmacotherapeutic management of advanced therapy drugs by Poveda-Andrés, José Luis, Ruiz-Caldes, María José, Carrera-Soler, María José, Clopés-Estela, Ana, Flores-Moreno, Sandra, García-Pellicer, Javier, Giráldez-Quiroga, Míriam, López-Briz, Eduardo, Lozano-Blázquez, Ana, Megías-Vericat, Juan Eduardo, Tordera-Baviera, María, Valero-García, Silvia

“…Advanced therapy drugs have emerged in recent years as new pharmacotherapeutic strategies. In this context, hospital pharmacy services have had to adapt to the…”
Get more information

Recommendations for the safety preparation of sterile medicines in medical wards by Martín de Rosales Cabrera, Ana M, López Cabezas, Carmen, Pernía López, M Sagrario, Dávila Pousa, Carmela, Vila Clérigues, M Nieves, Alonso Herreros, José María, García Salom, Pedro, Lozano Blázquez, Ana

“…To develop a recommendations guide about the preparation of sterile medicines in medical wards, and to figure out the current situation of different Spanish…”
Get more information